Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2016 1
2018 2
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %
The following terms were not found in PubMed: 20Katz
Page 1
Multimodal Facial Aesthetic Treatment on the Appearance of Aging, Social Confidence, and Psychological Well-being: HARMONY Study.
Cohen JL, Rivkin A, Dayan S, Shamban A, Werschler WP, Teller CF, Kaminer MS, Sykes JM, Weinkle SH, Garcia JK. Cohen JL, et al. Aesthet Surg J. 2022 Jan 12;42(2):NP115-NP124. doi: 10.1093/asj/sjab114. Aesthet Surg J. 2022. PMID: 33751048 Free PMC article.
METHODS: HARMONY, a prospective, multicenter, 4-month study, enrolled patients aged 35 to 65 years to receive on-label treatment with a combination of hyaluronic fillers (VYC-20L, HYC-24L, and/or HYC-24L+), onabotulinumtoxinA, and bimatoprost. ...
METHODS: HARMONY, a prospective, multicenter, 4-month study, enrolled patients aged 35 to 65 years to receive on-label treatment with a comb …
In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases.
Shumate GT, Chopra R, Jones D, Messina DJ, Hee CK. Shumate GT, et al. Dermatol Surg. 2018 Aug;44(8):1075-1083. doi: 10.1097/DSS.0000000000001525. Dermatol Surg. 2018. PMID: 29659410
MATERIALS AND METHODS: Rats were injected with 3 HA fillers (HYC-24L+, VYC-20L, and RES-L) to create a projecting bolus. After 4 days, recombinant human hyaluronidase (HX) or ovine hyaluronidase (VIT) was administered at (1) varying doses (5 U, 10 U, or 30 U per 0.1 mL fil …
MATERIALS AND METHODS: Rats were injected with 3 HA fillers (HYC-24L+, VYC-20L, and RES-L) to create a projecting bolus. After 4 days …
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function.
Pavord ID, Siddiqui S, Papi A, Corren J, Sher LD, Bardin P, Langton D, Park HS, Rice MS, Deniz Y, Rowe P, Staudinger HW, Patel N, Ruddy M, Graham NMH, Teper A. Pavord ID, et al. J Asthma Allergy. 2020 Dec 16;13:701-711. doi: 10.2147/JAA.S275068. eCollection 2020. J Asthma Allergy. 2020. PMID: 33364789 Free PMC article.
RESULTS: In patients with elevated baseline eosinophils, dupilumab 200 mg and 300 mg q2w vs placebo reduced severe exacerbation rates by 50% (P=0.06) and 67% (P=0.001), respectively, in those with medium-dose ICS/FEV(1)% predicted 60-90%, and by 59% (P<0.001) and 47% (P=0.006) …
RESULTS: In patients with elevated baseline eosinophils, dupilumab 200 mg and 300 mg q2w vs placebo reduced severe exacerbation rates by 50% …
Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study.
Weinkle SH, Werschler WP, Teller CF, Sykes JM, Shamban A, Rivkin A, Narurkar VA, Kaminer MS, Dayan S, Cohen JL, Gallagher CJ. Weinkle SH, et al. Aesthet Surg J. 2018 Apr 6;38(5):540-556. doi: 10.1093/asj/sjx179. Aesthet Surg J. 2018. PMID: 29244069 Clinical Trial.
METHODS: Prospective, multicenter, rater-blinded, 4-month HARMONY study evaluated patient satisfaction and aesthetic impact of a combination of fillers (VYC-20L, HYC-24L, and HYC-24L+), onabotulinumtoxinA, and bimatoprost. ...
METHODS: Prospective, multicenter, rater-blinded, 4-month HARMONY study evaluated patient satisfaction and aesthetic impact of a combination …
Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study.
Jones D, Murphy DK. Jones D, et al. Dermatol Surg. 2013 Nov;39(11):1602-12. doi: 10.1111/dsu.12343. Epub 2013 Oct 4. Dermatol Surg. 2013. PMID: 24093664 Free article. Clinical Trial.
OBJECTIVE: To study the safety and effectiveness of a new 20-mg/mL HA gel (VYC-20L) specifically formulated and optimized for mid-face volumizing. ...CONCLUSION: VYC-20L is safe and effective for age-related MVD, with correction lasting up to 2 years....
OBJECTIVE: To study the safety and effectiveness of a new 20-mg/mL HA gel (VYC-20L) specifically formulated and optimized for mid-fac …
A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study.
Narurkar VA, Cohen JL, Dayan S, Kaminer MS, Rivkin A, Shamban A, Sykes JM, Teller CF, Weinkle SH, Werschler WP, Drinkwater A, Pucci ML, Gallagher CJ. Narurkar VA, et al. Dermatol Surg. 2016 May;42 Suppl 2:S177-91. doi: 10.1097/DSS.0000000000000743. Dermatol Surg. 2016. PMID: 27128246 Clinical Trial.
METHODS: This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L (Juvederm Voluma XC), HYC-24L (Juvederm Ultra XC), HYC-24L+ (Juvederm Ultra Plus XC), onabotulinumtoxinA (Botox), and bimatoprost 0.3% o …
METHODS: This multicenter, 4-month study evaluated subject satisfaction with and psychological impact of combined treatment with VYC-20L …
Measurement of semileptonic B decays into orbitally excited charmed mesons.
Aubert B, Bona M, Karyotakis Y, Lees JP, Poireau V, Prencipe E, Prudent X, Tisserand V, Garra Tico J, Grauges E, Lopez L, Palano A, Pappagallo M, Eigen G, Stugu B, Sun L, Abrams GS, Battaglia M, Brown DN, Cahn RN, Jacobsen RG, Kerth LT, Kolomensky YG, Lynch G, Osipenkov IL, Ronan MT, Tackmann K, Tanabe T, Hawkes CM, Soni N, Watson AT, Koch H, Schroeder T, Walker D, Asgeirsson DJ, Fulsom BG, Hearty C, Mattison TS, McKenna JA, Barrett M, Khan A, Blinov VE, Bukin AD, Buzykaev AR, Druzhinin VP, Golubev VB, Onuchin AP, Serednyakov SI, Skovpen YI, Solodov EP, Todyshev KY, Bondioli M, Curry S, Eschrich I, Kirkby D, Lankford AJ, Lund P, Mandelkern M, Martin EC, Stoker DP, Abachi S, Buchanan C, Gary JW, Liu F, Long O, Shen BC, Vitug GM, Yasin Z, Zhang L, Sharma V, Campagnari C, Hong TM, Kovalskyi D, Mazur MA, Richman JD, Beck TW, Eisner AM, Flacco CJ, Heusch CA, Kroseberg J, Lockman WS, Martinez AJ, Schalk T, Schumm BA, Seiden A, Wilson MG, Winstrom LO, Cheng CH, Doll DA, Echenard B, Fang F, Hitlin DG, Narsky I, Piatenko T, Porter FC, Andreassen R, Mancinelli G, Meadows BT, Mishra K, Sokoloff MD, Bloom PC, Ford WT, Gaz A, Hirschauer JF, Nagel M, Nauenberg U, Smith JG, Ulmer KA, Wagner SR, … See abstract for full author list ➔ Aubert B, et al. Phys Rev Lett. 2009 Jul 31;103(5):051803. doi: 10.1103/PhysRevLett.103.051803. Epub 2009 Jul 31. Phys Rev Lett. 2009. PMID: 19792487 Free article.